Exact Mass: 537.1347499999999
Exact Mass Matches: 537.1347499999999
Found 76 metabolites which its exact mass value is equals to given mass value 537.1347499999999,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Dynemicin A
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D000970 - Antineoplastic Agents
3-Demethylsimmondsin 2'-(Z)-ferulate
3-Demethylsimmondsin 2-(Z)-ferulate is found in coffee and coffee products. 3-Demethylsimmondsin 2-(Z)-ferulate is a constituent of jojoba meal Constituent of jojoba meal. 3-Demethylsimmondsin 2-(Z)-ferulate is found in coffee and coffee products, fats and oils, and nuts.
4-Demethylsimmondsin 2'-(E)-ferulate
4-Demethylsimmondsin 2-(E)-ferulate is found in coffee and coffee products. 4-Demethylsimmondsin 2-(E)-ferulate is a constituent of jojoba meal Constituent of jojoba meal. 4-Demethylsimmondsin 2-(E)-ferulate is found in coffee and coffee products, fats and oils, and nuts.
N-[4-[(4As)-1,2,4,4a,5,11-hexahydro-[1,4]oxazino[3,4-c][1,4]benzodiazepine-6-carbonyl]-3-chlorophenyl]-2-phenylbenzamide
C32H28ClN3O3 (537.1819088000001)
Desmethyl Bosentan
LACCAIC ACID A
C26H19NO12 (537.0907214000001)
A tetrahydroxyanthraquinone that is that is 3,5,6,8-tetrahydroxy-9,10-anthraquinone substituted by two carboxy groups at positions 1 and 2 as well as a 5-(2-acetamidoethyl)-2-hydroxyphenyl group at position 7. The major component of LAC dye together with laccaic acids B, C and D
4-(2-hydroxyethyl)phenyl 5-O-nicotinyl-beta-D-apiofuranosyl(1->2)-beta-D-glucopyranoside|cucurbitoside H
Cys Asp Asp Trp
C22H27N5O9S (537.1529412000001)
Cys Asp Trp Asp
C22H27N5O9S (537.1529412000001)
Cys Trp Asp Asp
C22H27N5O9S (537.1529412000001)
Asp Cys Asp Trp
C22H27N5O9S (537.1529412000001)
Asp Cys Trp Asp
C22H27N5O9S (537.1529412000001)
Asp Asp Cys Trp
C22H27N5O9S (537.1529412000001)
Asp Asp Trp Cys
C22H27N5O9S (537.1529412000001)
Asp Trp Cys Asp
C22H27N5O9S (537.1529412000001)
Asp Trp Asp Cys
C22H27N5O9S (537.1529412000001)
Trp Cys Asp Asp
C22H27N5O9S (537.1529412000001)
Trp Asp Cys Asp
C22H27N5O9S (537.1529412000001)
Trp Asp Asp Cys
C22H27N5O9S (537.1529412000001)
4-Demethylsimmondsin 2'-(E)-ferulate
3-Demethylsimmondsin 2'-(Z)-ferulate
Methanesulfonamide,N-[5-[(diphenylphosphinyl)methyl]-4-(4-fluorophenyl)-6-(1-methylethyl)-2-pyrimidinyl]-N-methyl
(-)-2,3-Bis[(2R,5R)-2,5-dimethylphospholanyl]-1-[3,5-bis(trifluoromethyl)phenyl]-1H-pyrrole-2,5-dione
N-{4-[4-Amino-6-(4-methoxyphenyl)furo[2,3-D]pyrimidin-5-YL]phenyl}-N-[2-fluoro-5-(trifluoromethyl)phenyl]urea
N-[4-[(4As)-1,2,4,4a,5,11-hexahydro-[1,4]oxazino[3,4-c][1,4]benzodiazepine-6-carbonyl]-3-chlorophenyl]-2-phenylbenzamide
C32H28ClN3O3 (537.1819088000001)
4-(Diethylsulfamoyl)benzoic acid [2-[4-(6-methyl-1,3-benzothiazol-2-yl)anilino]-2-oxoethyl] ester
C27H27N3O5S2 (537.1392052000001)
6-Chloro-3-[5-(2,3-dimethoxyphenyl)-1-methylsulfonyl-3-pyrazolidinylidene]-4-phenyl-2-quinolinone
6-Chloro-3-[5-(2,5-dimethoxyphenyl)-1-methylsulfonyl-3-pyrazolidinylidene]-4-phenyl-2-quinolinone
N-[3,5-dimethyl-1-[(4-methylphenyl)methyl]-4-pyrazolyl]-2-[[4-(trifluoromethyl)-5,6-dihydrobenzo[h]quinazolin-2-yl]thio]acetamide
C28H26F3N5OS (537.1810062000001)
2-[(2,5-dimethylphenyl)sulfonylamino]-N-[4-(2-pyrimidinylsulfamoyl)phenyl]benzamide
C25H23N5O5S2 (537.1140548000001)
N-naphthalen-2-yl-2-[[6-[[2-(naphthalen-2-ylamino)-2-oxoethyl]sulfanylmethyl]pyridin-2-yl]methylsulfanyl]acetamide
6-O-(2-amino-2-deoxy-alpha-D-glucosyl)-1D-myo-inositol 1-(6-mercaptohexyl)phosphate
[2-[[4-[(2,4-Dioxo-1,3-thiazolidin-5-yl)methyl]phenoxy]methyl]-5-(hydroxymethyl)-2,7,8-trimethyl-3,4-dihydrochromen-6-yl] hydrogen sulfate
C24H27NO9S2 (537.1127172000001)
CID 5281927
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D000970 - Antineoplastic Agents
AR-C118925XX
AR-C118925XX is a selective P2Y2 receptor antagonist. AR-C118925XX inhibits ATP-induced IL-6 production and phosphorylation of p38. AR-C118925XX also inhibits Bleomycin (HY-108345)-induced dermal fibrosis in mice. AR-C118925XX also inhibits ATP-induced tumor growth[1][2].
OP-5244
OP-5244 is a potent and orally active inhibitor of CD73, with an IC50 of 0.25 nM. OP-5244 reverses immunosuppression through blocking of adenosine production, and has the potential for the cancer research[1].
(1r,14s,15r)-15-{[(5ar,6r,8r,9r,9as)-8-(hydroxymethyl)-9-methoxy-hexahydro-2h-pyrano[3,4-f][1,3,5]trioxepin-6-yl]oxy}-14-hydroxy-5,7-dioxa-12-azatetracyclo[10.5.2.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9-triene-13,17-dione
2-{[2-(cyanomethylidene)-3,5-dihydroxy-4-methoxycyclohexyl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl 3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate
(2r,3r,4s,5s,6r)-2-{[(1r,2z,3s,4r,5s)-2-(cyanomethylidene)-3,4-dihydroxy-5-methoxycyclohexyl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl (2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate
(5-{[4,5-dihydroxy-6-(hydroxymethyl)-2-[4-(hydroxymethyl)phenoxy]oxan-3-yl]oxy}-3,4-dihydroxyoxolan-3-yl)methyl 4-aminobenzoate
2-{[2-(cyanomethylidene)-3,4-dihydroxy-5-methoxycyclohexyl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl 3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate
[(3s,4r,5s)-5-{[(2s,3r,4s,5s,6r)-4,5-dihydroxy-2-[4-(2-hydroxyethyl)phenoxy]-6-(hydroxymethyl)oxan-3-yl]oxy}-3,4-dihydroxyoxolan-3-yl]methyl pyridine-3-carboxylate
(1s,14s,15r)-15-{[(5ar,6r,8r,9r,9as)-8-(hydroxymethyl)-9-methoxy-hexahydro-2h-pyrano[3,4-f][1,3,5]trioxepin-6-yl]oxy}-14-hydroxy-5,7-dioxa-12-azatetracyclo[10.5.2.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9-triene-13,17-dione
(3s,6r)-19-{[(2s,4r,5r,6s)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-11-hydroxy-3-[(1r)-1-hydroxyethyl]-9-methyl-5-oxa-2-azapentacyclo[11.8.0.0²,⁶.0⁷,¹².0¹⁵,²⁰]henicosa-1(13),7,9,11,15,17,19-heptaene-4,14,21-trione
C28H27NO10 (537.1634882000001)
[5-({4,5-dihydroxy-2-[4-(2-hydroxyethyl)phenoxy]-6-(hydroxymethyl)oxan-3-yl}oxy)-3,4-dihydroxyoxolan-3-yl]methyl pyridine-3-carboxylate
3-[3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]-6,20-difluoro-14-hydroxy-3,13,23-triazahexacyclo[14.7.0.0²,¹⁰.0⁴,⁹.0¹¹,¹⁵.0¹⁷,²²]tricosa-1(16),2(10),4(9),5,7,11(15),13,17(22),18,20-decaen-12-one
C27H21F2N3O7 (537.1347499999999)
[(3s,4r,5s)-5-{[(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-2-[4-(hydroxymethyl)phenoxy]oxan-3-yl]oxy}-3,4-dihydroxyoxolan-3-yl]methyl 4-aminobenzoate
3-[(2r,3r,4r,5s,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]-6,20-difluoro-14-hydroxy-3,13,23-triazahexacyclo[14.7.0.0²,¹⁰.0⁴,⁹.0¹¹,¹⁵.0¹⁷,²²]tricosa-1(16),2(10),4(9),5,7,11(15),13,17(22),18,20-decaen-12-one
C27H21F2N3O7 (537.1347499999999)
(2s,3r,4s,5r,6r)-2-hydroxy-4,5-bis[(3-nitropropanoyl)oxy]-6-{[(3-nitropropanoyl)oxy]methyl}oxan-3-yl prop-2-enoate
(2s,4r,5r,8s,11z,15r)-21,24,28-trihydroxy-7-methoxy-5-methyl-19,26-dioxo-3-oxa-16-azaheptacyclo[15.12.0.0²,⁴.0²,⁸.0⁴,¹⁵.0¹⁸,²⁷.0²⁰,²⁵]nonacosa-1(29),6,11,17,20,22,24,27-octaen-9,13-diyne-6-carboxylic acid
(1r,3s,4r,5r,7r,9r,11s,12s,13s)-5-(6-aminopurin-9-yl)-1,12-dihydroxy-13-{[(2e)-2-(hydroxymethyl)but-2-enoyl]oxy}-4-methoxy-2,6,10-trioxatricyclo[7.4.0.0³,⁷]tridecane-11-carboxylic acid
C22H27N5O11 (537.1706992000001)
(3s,6s)-19-{[(2s,4r,5r,6s)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-11-hydroxy-3-[(1r)-1-hydroxyethyl]-9-methyl-5-oxa-2-azapentacyclo[11.8.0.0²,⁶.0⁷,¹².0¹⁵,²⁰]henicosa-1(13),7,9,11,15,17,19-heptaene-4,14,21-trione
C28H27NO10 (537.1634882000001)
(2r,4s,5s,8s,11z)-21,24,28-trihydroxy-7-methoxy-5-methyl-19,26-dioxo-3-oxa-16-azaheptacyclo[15.12.0.0²,⁴.0²,⁸.0⁴,¹⁵.0¹⁸,²⁷.0²⁰,²⁵]nonacosa-1(29),6,11,17,20,22,24,27-octaen-9,13-diyne-6-carboxylic acid
(2r,3r,4s,5s,6r)-2-{[(1r,2z,3s,4s,5s)-2-(cyanomethylidene)-3,5-dihydroxy-4-methoxycyclohexyl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl (2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate
[(3s,4r,5s)-5-{[(2s,3r,4s,5s,6r)-4,5-dihydroxy-2-[4-(2-hydroxyethyl)phenoxy]-6-(hydroxymethyl)oxan-3-yl]oxy}-3,4-dihydroxyoxolan-3-yl]methyl pyridine-2-carboxylate
19-[(4,5-dihydroxy-6-methyloxan-2-yl)oxy]-11-hydroxy-3-(1-hydroxyethyl)-9-methyl-5-oxa-2-azapentacyclo[11.8.0.0²,⁶.0⁷,¹².0¹⁵,²⁰]henicosa-1(13),7,9,11,15,17,19-heptaene-4,14,21-trione
C28H27NO10 (537.1634882000001)